Homology Modeling and Docking Analysis of the Interaction between Polyphenols and Mammalian 20S Proteasomes

Molecular docking of small ligands to biologically active macromolecules has become a valuable strategy to predict the stability of complexes between potential partners and their binding modes. In this perspective, we applied this computational procedure to rationalize the reported role of polyphenols as inhibitors of the mammalian 20S proteasomes. In particular, polyphenols were shown to modulate each proteasomal activity at different extents both in the constitutive and the inducible enzyme. We performed a flexible molecular docking analysis between a set of polyphenols previously demonstrated to have the highest binding affinity and both the constitutive (from deposited PDB structures) and homology modeled active subunits of the IFN-gamma inducible proteasome, to provide insight into the possible mechanism of interaction. Among the tested polyphenols, (-)-epigallocatechin-3-gallate showed the highest affinity for the proteasome subunits, both in terms of intermolecular energy and predicted equilibrium constants, in particular for beta5 and beta5i subunits (E(total) = -66 kcal/mol, Ki = 81.3 microM and E(Total) = -83.9 kcal/mol, Ki = 0.29 microM, respectively), known to be related to the chymotrypsin-like and BrAAP activities. Collectively, polyphenols showed a higher affinity for the inducible subunits, in agreement with previous in vitro studies. Additionally, different contributions to the interaction energy (van der Waals, electrostatic, H-bond) of proteasome-polyphenols complexes were dissected.

[1]  A. Jedinák,et al.  Inhibition activities of natural products on serine proteases , 2006, Phytotherapy research : PTR.

[2]  R. Huber,et al.  Crystal structure of the 20 S proteasome:TMC-95A complex: a non-covalent proteasome inhibitor. , 2001, Journal of molecular biology.

[3]  Ying Xu,et al.  Structure‐based prediction of transcription factor binding sites using a protein‐DNA docking approach , 2008, Proteins.

[4]  R. Huber,et al.  Structure of 20S proteasome from yeast at 2.4Å resolution , 1997, Nature.

[5]  H. Ploegh,et al.  Crystal structure of the boronic acid-based proteasome inhibitor bortezomib in complex with the yeast 20S proteasome. , 2006, Structure.

[6]  P. Cresswell,et al.  Mechanisms of MHC class I--restricted antigen processing. , 1998, Annual review of immunology.

[7]  Thomas L. James,et al.  Docking to RNA via Root-Mean-Square-Deviation-Driven Energy Minimization with Flexible Ligands and Flexible Targets , 2008, J. Chem. Inf. Model..

[8]  Hans-Joachim Böhm,et al.  Prediction of binding constants of protein ligands: A fast method for the prioritization of hits obtained from de novo design or 3D database search programs , 1998, J. Comput. Aided Mol. Des..

[9]  M. Mozzicafreddo,et al.  Antiplasmin activity of natural occurring polyphenols. , 2008, Biochimica et biophysica acta.

[10]  M. Mozzicafreddo,et al.  Flavonoids inhibit the amidolytic activity of human thrombin. , 2006, Biochimie.

[11]  F. Sarkar,et al.  Genistein inhibits NF-kappa B activation in prostate cancer cells. , 1999, Nutrition and cancer.

[12]  S. Wodak,et al.  Docking and scoring protein complexes: CAPRI 3rd Edition , 2007, Proteins.

[13]  A. Murzin,et al.  A protein catalytic framework with an N-terminal nucleophile is capable of self-activation , 1995, Nature.

[14]  D. Kuhn,et al.  Direct inhibition of the ubiquitin-proteasome pathway by ester bond-containing green tea polyphenols is associated with increased expression of sterol regulatory element-binding protein 2 and LDL receptor. , 2004, Biochimica et biophysica acta.

[15]  M. Angeletti,et al.  Isolation and characterization of bovine thymus multicatalytic proteinase complex. , 2000, Protein expression and purification.

[16]  A. Goldberg Functions of the proteasome: the lysis at the end of the tunnel. , 1995, Science.

[17]  Di Chen,et al.  Dietary flavonoids as proteasome inhibitors and apoptosis inducers in human leukemia cells. , 2005, Biochemical pharmacology.

[18]  R. Huber,et al.  The proteasome. , 1999, Annual review of biophysics and biomolecular structure.

[19]  R. Huber,et al.  Crystal structures of Salinosporamide A (NPI-0052) and B (NPI-0047) in complex with the 20S proteasome reveal important consequences of beta-lactone ring opening and a mechanism for irreversible binding. , 2006, Journal of the American Chemical Society.

[20]  F. García-Cánovas,et al.  Kinetics of the inhibition of bovine liver dihydrofolate reductase by tea catechins: origin of slow-binding inhibition and pH studies. , 2005, Biochemistry.

[21]  R. Abagyan,et al.  Optimal docking area: A new method for predicting protein–protein interaction sites , 2004, Proteins.

[22]  Akbar Nayeem,et al.  A comparative study of available software for high‐accuracy homology modeling: From sequence alignments to structural models , 2006, Protein science : a publication of the Protein Society.

[23]  G Klebe,et al.  Docking ligands onto binding site representations derived from proteins built by homology modelling. , 2001, Journal of molecular biology.

[24]  A. Goldberg,et al.  Degradation of cell proteins and the generation of MHC class I-presented peptides. , 1999, Annual review of immunology.

[25]  T. Mizushima,et al.  The structure of the mammalian 20S proteasome at 2.75 A resolution. , 2002, Structure.

[26]  C. Rice-Evans,et al.  The polyphenolic content of fruit and vegetables and their antioxidant activities. What does a serving constitute? , 1999, Free radical research.

[27]  P. Kloetzel,et al.  Ubiquitin and proteasomes: Antigen processing by the proteasome , 2001, Nature Reviews Molecular Cell Biology.

[28]  Di Chen,et al.  Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis inducers in human breast cancer cells , 2005, Breast Cancer Research.

[29]  M Orlowski,et al.  Evidence for the presence of five distinct proteolytic components in the pituitary multicatalytic proteinase complex. Properties of two components cleaving bonds on the carboxyl side of branched chain and small neutral amino acids. , 1993, Biochemistry.

[30]  F. Nanjo,et al.  Scavenging effects of tea catechins and their derivatives on 1,1-diphenyl-2-picrylhydrazyl radical. , 1996, Free radical biology & medicine.

[31]  K Tanaka,et al.  Structure and functions of the 20S and 26S proteasomes. , 1996, Annual review of biochemistry.

[32]  K Eichmann,et al.  The specificity of proteasomes: impact on MHC class I processing and presentation of antigens , 1999, Immunological reviews.

[33]  A. Miller,et al.  Diet and cancer. A review. , 1990, Acta oncologica.

[34]  J. Freedman,et al.  Grape Seed and Skin Extracts Inhibit Platelet Function and Release of Reactive Oxygen Intermediates , 2005, Journal of cardiovascular pharmacology.

[35]  F. García-Cánovas,et al.  The antifolate activity of tea catechins. , 2005, Cancer research.

[36]  David M. Smith,et al.  Ester Bond-containing Tea Polyphenols Potently Inhibit Proteasome Activity in Vitro and in Vivo * , 2001, The Journal of Biological Chemistry.

[37]  K. Kasai,et al.  Determination of the affinity constants of concanavalin A for monosaccharides by fluorescence affinity probe capillary electrophoresis. , 1995, Analytical biochemistry.

[38]  R. Huber,et al.  Crystal Structure of Epoxomicin:20S Proteasome reveals a molecular basis for selectivity of alpha,beta-Epoxyketone Proteasome Inhibitors , 2000 .

[39]  Ilya A Vakser,et al.  Interaction cutoff effect on ruggedness of protein–protein energy landscape , 2007, Proteins.

[40]  Barry S. Cooperman,et al.  Molecular Docking of Cathepsin L Inhibitors in the Binding Site of Papain , 2010, J. Chem. Inf. Model..

[41]  W. Baumeister,et al.  Autocatalytic processing of the 20S proteasome , 1996, Nature.

[42]  M. Angeletti,et al.  Peroxynitrite-induced oxidation and its effects on isolated proteasomal systems. , 2003, Free radical biology & medicine.

[43]  Susan Biggin,et al.  Inhibition of matrix-proteases by polyphenols: chemical insights for anti-inflammatory and anti-invasion drug design. , 2002, Biochemical pharmacology.

[44]  M. Angeletti,et al.  Effect of polyphenolic compounds on the proteolytic activities of constitutive and immuno-proteasomes. , 2006, Antioxidants & redox signaling.

[45]  R. Huber,et al.  A gated channel into the proteasome core particle , 2000, Nature Structural Biology.

[46]  T. Blundell,et al.  Knowledge-based protein modeling. , 1994, Critical reviews in biochemistry and molecular biology.

[47]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[48]  D. Pérahia,et al.  Normal mode analysis as a prerequisite for drug design: Application to matrix metalloproteinases inhibitors , 2006, FEBS letters.

[49]  G. Tipoe,et al.  Green tea polyphenols as an anti-oxidant and anti-inflammatory agent for cardiovascular protection. , 2007, Cardiovascular & hematological disorders drug targets.

[50]  M. Brunori,et al.  Evidence for two oxygen-linked binding sites for polyanions in dromedary hemoglobin. , 1985, European journal of biochemistry.

[51]  Jon M. Kleinberg,et al.  Fast detection of common geometric substructure in proteins , 1999, J. Comput. Biol..

[52]  M J Sternberg,et al.  Predictive docking of protein-protein and protein-DNA complexes. , 1998, Current opinion in structural biology.

[53]  C. Hill,et al.  THE 1.9 ANGSTROM STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX AND IMPLICATIONS FOR THE PROTEASOME-PAN/PA700 INTERACTIONS , 2005 .

[54]  A. Siraki,et al.  Dietary flavonoid iron complexes as cytoprotective superoxide radical scavengers. , 2003, Free radical biology & medicine.

[55]  R. Huber,et al.  Inhibitors of the eukaryotic 20S proteasome core particle: a structural approach. , 2004, Biochimica et biophysica acta.

[56]  Manuel C. Peitsch,et al.  SWISS-MODEL: an automated protein homology-modeling server , 2003, Nucleic Acids Res..

[57]  K. Kristan,et al.  Flavonoids and cinnamic acid esters as inhibitors of fungal 17beta-hydroxysteroid dehydrogenase: a synthesis, QSAR and modelling study. , 2006, Bioorganic & medicinal chemistry.

[58]  M. Melzig,et al.  Inhibition of neutrophil elastase activity by phenolic compounds from plants. , 2001, Die Pharmazie.

[59]  T. Yokozawa,et al.  Study on the Inhibitory Effect of Tannins and Flavonoids against the 1,1-Diphenyl-2-picrylhydrazyl Radical - A newly found effect of hydrolysable-type tannin-containing crude drug and gallotannin , 1998 .

[60]  T. Lybrand Ligand-protein docking and rational drug design. , 1995, Current Opinion in Structural Biology.

[61]  G J Kleywegt,et al.  Phi/psi-chology: Ramachandran revisited. , 1996, Structure.

[62]  W. Guida,et al.  Docking studies and model development of tea polyphenol proteasome inhibitors: Applications to rational drug design , 2003, Proteins.

[63]  H. Akiyama,et al.  Antiallergic effect of apple polyphenols on the allergic model mouse. , 2000, Biological & pharmaceutical bulletin.

[64]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[65]  O. Dangles,et al.  Binding of flavonoids to plasma proteins. , 2001, Methods in enzymology.

[66]  Y Hanasaki,et al.  The correlation between active oxygens scavenging and antioxidative effects of flavonoids. , 1994, Free radical biology & medicine.

[67]  M. Mozzicafreddo,et al.  Mechanism of inhibition of wt‐dihydrofolate reductase from E. coli by tea epigallocatechin‐gallate , 2008, Proteins.

[68]  Myoung H. Kim Flavonoids inhibit VEGF/bFGF‐induced angiogenesis in vitro by inhibiting the matrix‐degrading proteases , 2003, Journal of cellular biochemistry.

[69]  Marcela Madrid,et al.  Docking of non‐nucleoside inhibitors: Neotripterifordin and its derivatives to HIV‐1 reverse transcriptase , 2002, Proteins.